Last reviewed · How we verify

PRGF/ATV — Competitive Intelligence Brief

PRGF/ATV (PRGF/ATV) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Autologous cell/tissue therapy with growth factor concentrate. Area: Orthopedics / Regenerative Medicine.

marketed Autologous cell/tissue therapy with growth factor concentrate Orthopedics / Regenerative Medicine Small molecule Live · refreshed every 30 min

Target snapshot

PRGF/ATV (PRGF/ATV) — Ain Shams University. PRGF/ATV is a platelet-rich growth factor combined with autologous tenocyte therapy designed to promote tissue regeneration and repair.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
PRGF/ATV TARGET PRGF/ATV Ain Shams University marketed Autologous cell/tissue therapy with growth factor concentrate

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Autologous cell/tissue therapy with growth factor concentrate class)

  1. Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). PRGF/ATV — Competitive Intelligence Brief. https://druglandscape.com/ci/prgf-atv. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: